UnitedHealth Group (UNH) is trading higher after posting a stronger-than-expected first quarter and lifting its full-year profit outlook. The company reported Q1 2026 earnings of $6.90 per share and adjusted earnings of $7.23 per share, alongside revenue of about $111.7 billion, which came in ahead of consensus expectations. Management raised its full-year 2026 earnings outlook to greater than $17.35 per share and adjusted earnings to greater than $18.25 per share, signaling improved confidence in full-year performance.

The biggest catalyst is the guidance raise, which suggests the business is stabilizing after a volatile stretch for managed care names driven by medical cost uncertainty and Medicare Advantage reimbursement concerns. Investors are interpreting the beat-and-raise combination as evidence that cost and utilization trends were better controlled than feared, improving visibility into 2026 earnings power.

Focus is likely to remain on medical cost ratio trends, Medicare Advantage pricing discipline, and whether Optum’s performance continues to normalize. Investors will also watch for additional analyst target changes following the print, as the market recalibrates expectations for how quickly earnings momentum can rebuild through 2026.